• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊“腺瘤内癌”及腺瘤的p53和Ki-67免疫反应性与细胞核形态测定

p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.

作者信息

Takei K, Watanabe H, Itoi T, Saito T

机构信息

First Department of Pathology, Niigata University School of Medicine, Japan.

出版信息

Pathol Int. 1996 Nov;46(11):908-17. doi: 10.1111/j.1440-1827.1996.tb03569.x.

DOI:10.1111/j.1440-1827.1996.tb03569.x
PMID:8970203
Abstract

Twenty intramucosal tumors of "carcinoma-in-adenoma' and 43 adenomas (39 pyloric gland type, 4 intestinal type) of the gall-bladder were studied to establish more precise histological criteria of carcinoma or adenoma in cases of "carcinoma in pyloric gland type adenoma', to compare carcinoma in adenoma with pure, that is, without adenomatous components, carcinoma, and to confirm the benign nature of spindle cell foci in the adenomas. Ki-67 and p53 immunostaining and nuclear morphometry were used. Eight pure intramucosal cancers were used as controls. The formalin-fixed, paraffin-embedded sections were stained with p53 and Ki-67 antibodies. Spindle cell foci were observed only in the adenoma area of the pyloric gland type, with a frequency of 23% in 39 adenomas, and of 45% in 20 tumors of carcinoma-in-adenoma. Ki-67 staining was negative in 129 of 130 spindle cell foci examined, regardless of their size, and positive in only one focus (550 microns in size, Ki-67 index 0.2%). All of the spindle cell foci were negative for p53 stain. The Ki-67 positive index was 36.6 +/- 5.6% in the 8 pure carcinomas, and 12.5 +/- 1.9% in the cancer areas of 16 tumors with carcinoma-in-adenoma, while it was 7.9 +/- 1.7% in the adenoma areas of 16 tumors with carcinoma-in-adenoma and 4.9 +/- 0.5% in the 32 pure pyloric gland adenomas. The p53-protein over-expression was found in seven of eight pure intramucosal cancers, and in one of 16 cancer components of carcinoma-in-adenoma. However, it was not found in any of 16 adenoma components of carcinoma-in-adenoma, and 35 adenomas. Cells of the cancer tissue of carcinoma-in-adenoma showed a significantly larger nuclear area and a larger nuclear minor axis than those of the pyloric gland type adenomas, as well as other architectural and cytologic abnormalities differing from the features of adenomas. These results suggest that clustered spindle cells do not indicate a malignant transformation of adenoma cells and that carcinomas in carcinoma-in-adenoma are different from pyloric gland type adenomas in terms of morphology and proliferative activity. Moreover, the results of the present study indicate that carcinomas in carcinoma-in-adenoma are lower in malignancy than pure carcinomas, and that their genetic abnormality may differ from that of pure carcinomas.

摘要

对20例“腺瘤内癌”的黏膜内肿瘤和43例胆囊腺瘤(39例幽门腺型,4例肠型)进行研究,以确立“幽门腺型腺瘤内癌”病例中癌或腺瘤更精确的组织学标准,比较腺瘤内癌与单纯癌(即无腺瘤成分的癌),并确认腺瘤中梭形细胞灶的良性性质。采用Ki-67和p53免疫染色及核形态计量学方法。8例单纯黏膜内癌用作对照。用p53和Ki-67抗体对福尔马林固定、石蜡包埋的切片进行染色。仅在幽门腺型腺瘤区域观察到梭形细胞灶,在39例腺瘤中的出现频率为23%,在20例腺瘤内癌肿瘤中的出现频率为45%。在所检查的130个梭形细胞灶中,129个Ki-67染色为阴性,无论其大小如何,仅1个灶(大小为550微米,Ki-67指数0.2%)为阳性。所有梭形细胞灶p53染色均为阴性。8例单纯癌的Ki-67阳性指数为36.6±5.6%,16例腺瘤内癌肿瘤的癌区域为12.5±1.9%,16例腺瘤内癌肿瘤的腺瘤区域为7.9±1.7%,32例单纯幽门腺腺瘤为4.9±0.5%。8例单纯黏膜内癌中有7例发现p53蛋白过度表达,16例腺瘤内癌的癌成分中有1例发现。然而,16例腺瘤内癌的腺瘤成分及35例腺瘤中均未发现。腺瘤内癌的癌组织细胞的核面积和核短轴明显大于幽门腺型腺瘤的细胞,以及存在与腺瘤特征不同的其他结构和细胞学异常。这些结果表明,聚集的梭形细胞并不表明腺瘤细胞发生恶性转化,腺瘤内癌的癌在形态和增殖活性方面与幽门腺型腺瘤不同。此外,本研究结果表明,腺瘤内癌的恶性程度低于单纯癌,其基因异常可能与单纯癌不同。

相似文献

1
p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.胆囊“腺瘤内癌”及腺瘤的p53和Ki-67免疫反应性与细胞核形态测定
Pathol Int. 1996 Nov;46(11):908-17. doi: 10.1111/j.1440-1827.1996.tb03569.x.
2
p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.胆囊“腺瘤内癌”及腺瘤的p53和Ki-67免疫反应性与细胞核形态测量
Pathol Int. 1996 Jun;46(6):426-35. doi: 10.1111/j.1440-1827.1996.tb03633.x.
3
Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.胆囊幽门腺型腺瘤中胃和胆管表型的共表达:黏蛋白谱和CD10的免疫组化分析
Oncol Rep. 2007 Apr;17(4):721-9.
4
Histological and genetic changes in malignant transformation of gallbladder adenoma.胆囊腺瘤恶性转化中的组织学和遗传学变化。
Ann Oncol. 1999;10 Suppl 4:136-9.
5
Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.涎腺基底细胞腺癌:通过评估细胞增殖、凋亡以及p53和bcl-2的表达与基底细胞腺瘤进行比较。
Cancer. 1998 Feb 1;82(3):439-47.
6
Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.肾上腺肿瘤中p53、MIB-1和增殖细胞核抗原的临床特征及免疫表达
J Urol. 2005 Jun;173(6):2138-42. doi: 10.1097/01.ju.0000157683.55748.41.
7
p53 expression patterns in colorectal adenomas and early carcinomas: a special reference to depressed adenoma and non-polypoid carcinoma.结直肠腺瘤和早期癌中的p53表达模式:特别提及凹陷型腺瘤和非息肉样癌。
Pathol Int. 1996 Dec;46(12):962-7. doi: 10.1111/j.1440-1827.1996.tb03575.x.
8
p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder.p53免疫染色可区分胆囊的恶性病变与良性病变。
Pathol Int. 1995 Jan;45(1):58-65. doi: 10.1111/j.1440-1827.1995.tb03380.x.
9
Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.伴有或不伴有腺瘤的壶腹癌:198例病例的临床病理分析及p53和Ki-67免疫组化表达情况
Mod Pathol. 2000 Dec;13(12):1300-7. doi: 10.1038/modpathol.3880238.
10
[Cyclo-oxygenase-2 and p53 immunoreactivity in superficial early colorectal carcinoma].[浅表早期结直肠癌中环氧化酶-2和p53免疫反应性]
Korean J Gastroenterol. 2006 May;47(5):350-6.

引用本文的文献

1
Detached pyloric gland adenoma of gallbladder: A case report and review of literature.胆囊分离性幽门腺腺瘤:一例报告并文献复习
Clin Case Rep. 2024 Oct 31;12(11):e9394. doi: 10.1002/ccr3.9394. eCollection 2024 Nov.
2
Helicobacter Infection and Gastric Adenoma.幽门螺杆菌感染与胃腺瘤
Microorganisms. 2021 Jan 5;9(1):108. doi: 10.3390/microorganisms9010108.
3
Pyloric Gland Adenoma of Gallbladder: A Review of Diagnosis and Management.胆囊幽门腺腺瘤:诊断与治疗综述
Adv Med. 2018 Dec 19;2018:7539694. doi: 10.1155/2018/7539694. eCollection 2018.
4
Bouveret's syndrome with a concomitant incidental T1 gallbladder cancer.伴有偶然发现的T1期胆囊癌的布韦雷特综合征
Clin J Gastroenterol. 2010 Oct;3(5):248-53. doi: 10.1007/s12328-010-0170-0. Epub 2010 Sep 4.
5
Pyloric gland adenoma: a case report.幽门腺腺瘤:一例报告。
Case Rep Gastroenterol. 2013 Sep 9;7(3):392-5. doi: 10.1159/000355342. eCollection 2013.
6
Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53.应用一系列黏蛋白 2、黏蛋白 5AC、黏蛋白 6、CD10、Ki67 和 p53 对幽门腺腺瘤进行免疫组织化学分析。
Virchows Arch. 2010 Nov;457(5):529-36. doi: 10.1007/s00428-010-0968-7. Epub 2010 Sep 9.
7
[Tubular adenoma of the stomach with special reference to the Japanese criteria and pyloric gland adenoma].[胃管状腺瘤,特别参考日本标准及幽门腺腺瘤]
Pathologe. 2010 May;31(3):177-81. doi: 10.1007/s00292-009-1267-4.
8
Aberrant expression of an "intestinal marker" Cdx2 in pyloric gland adenoma of the gallbladder.“肠道标志物”Cdx2在胆囊幽门腺腺瘤中的异常表达。
Virchows Arch. 2008 Nov;453(5):521-7. doi: 10.1007/s00428-008-0680-z. Epub 2008 Oct 9.
9
Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers.胆囊癌:p53 蛋白过表达和 Ki-67 抗原表达作为预后标志物的作用。
HPB (Oxford). 2004;6(3):174-80. doi: 10.1080/13651820410025110.
10
Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach.胃型高分化腺癌及胃幽门腺腺瘤
Gastric Cancer. 2006;9(3):177-84. doi: 10.1007/s10120-006-0381-8.